MS Studies on the Metabolomics Workbench Containing Lipids

These studies were depositied in the NIH Metabolomics Data Repository from institutions around the world, and are hosted on the Metabolomics Workbench. Search, sort, and filter using the options below. Links lead to the Metabolomics Workbench website.

EI: Electron ionization(GC-MS); ESI: Electrospray ionization (LC-MS)

Search:

  Records per page  

Fields searched:
Study Title, Institute, Subject Species, MS Type (case insensitive)

Study Title
Institute
Subject Species
MS Type
Number of lipids
Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium (ST000546) Monash University Plasmodium falciparum ESI 146
Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells (ST003565) Monash University Plasmodium falciparum ESI 287
Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii (ST003521) Monash University Acinetobacter baumannii ESI 119
?-Adrenergic regulation of metabolism in macrophages (part-II) (ST001548) Monash University Homo sapiens ESI 135
?-Adrenergic regulation of metabolism in macrophages (part-I) (ST001547) Monash University Homo sapiens ESI 153
Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria (ST002792) Monash University Plasmodium falciparum ESI 189
Targeting malaria parasites with novel derivatives of azithromycin (ST002309) Monash University Plasmodium falciparum ESI 113
Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression (ST002926) Monash University Plasmodium falciparum ESI 128
Retargeting azithromycin-like compounds as antimalarials with dual modality (ST001315) Monash University Plasmodium falciparum ESI 114
Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii (ST001304) Monash University Toxoplasma gondii ESI 199
Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics (ST003053) Monash University Staphylococcus aureus ESI 192
Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds (ST001276) Monash University Trypanosoma brucei brucei ESI 205
Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) (ST001275) Monash University Trypanosoma brucei brucei ESI 339
Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) (ST001274) Monash University Trypanosoma brucei brucei ESI 214
Determination of mode of action of anti-malalrial drugs using untargeted metabolomics (ST001033) Monash University Plasmodium falciparum ESI 135
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity (ST003144) Monash University Plasmodium falciparum ESI 190
New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites (ST003160) Monash University Plasmodium falciparum ESI 166
Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites (ST001205) Monash University Plasmodium falciparum;Homo sapiens ESI 234
Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 (ST003179) Monash University Plasmodium falciparum ESI 286
Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites (ST001204) Monash University Plasmodium falciparum;Homo sapiens ESI 200
Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites (ST001202) Monash University Plasmodium falciparum;Homo sapiens ESI 194
Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites (ST001201) Monash University Plasmodium falciparum;Homo sapiens ESI 167
Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) (ST002108) Monash University Plasmodium falciparum ESI 212
Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) (ST002107) Monash University Plasmodium falciparum ESI 152
Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum (ST001175) Monash University Plasmodium falciparum ESI 168
Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) (ST002106) Monash University Plasmodium falciparum ESI 113
?-Adrenergic regulation of metabolism in macrophages (part-IV) (ST001788) Monash University Homo sapiens ESI 210
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 (ST003024) Monash Institute of Pharmaceutical Sciences Pseudomonas aeruginosa ESI 34
Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) (ST001795) Monash Institute of Pharmaceutical Sciences Mus musculus ESI 349
Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action (ST000414) Monash Institute of Pharmaceutical Sciences Plasmodium falciparum ESI 148
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 (ST003036) Monash Institute of Pharmaceutical Sciences Pseudomonas aeruginosa ESI 136
Distinct Human Hepatocyte Lipidomics Profiles for Nonalcoholic Steatohepatitis and In Vitro-Induced Steatosis (ST002057) Monash Institute of Pharmaceutical Sciences Homo sapiens ESI 374
Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (ST000403) Monash Institute of Pharmaceutical Sciences Homo sapiens ESI 264
Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (ST001796) Monash Institute of Pharmaceutical Sciences Mus musculus ESI 356
Proteomic and metabolomic profiling of methicillin resistant versus methicillin sensitive Staphylococcus aureus using a simultaneous extraction protocol (ST003343) Mohammed Bin Rashid University of Medicine and Health Science Staphylococcus aureus ESI 23
Ontogeny related changes in the pediatric liver metabolome (part-II) (ST001403) Moffitt Cancer Center Homo sapiens ESI 253
Ontogeny related changes in the pediatric liver metabolome (ST001402) Moffitt Cancer Center Homo sapiens ESI 145
Targeting Sirt2 reprograms T cell metabolism for effective immune response (ST001373) Moffitt Cancer Center Mus musculus ESI 32
Ontogeny related changes in the pediatric liver metabolome (part-III) (ST001404) Moffitt Cancer Center Homo sapiens ESI 251
Role of cilia in mitochondrial function (ST002809) Medical University of South Carolina Mus musculus;Canis lupus familiaris ESI 317
Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. (ST002729) Medical Institute of Bioregulation, Kyushu University Mus musculus ESI 233
Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) (ST002759) Medical College of Wisconsin Rattus norvegicus ESI 140
Metabolic responses of normal rat kidneys to a high salt intake (Plasma) (ST002758) Medical College of Wisconsin Rattus norvegicus ESI 128
Metabolic responses of normal rat kidneys to a high salt intake (Urine) (ST002761) Medical College of Wisconsin Rattus norvegicus ESI 154
Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) (ST002760) Medical College of Wisconsin Rattus norvegicus ESI 120
Metabolic contribution of pSymA and pSymB megaplasmid/chromid for multipartite Sinorhizobium meliloti cultured in minimal M9 medium (ST000258) McMaster University Sinorhizobium meliloti ESI 54
Normal plasma cells,Low proliferation multiple myeloma and High proliferation multiple myeloma cells (ST000221) Mayo Clinic Homo sapiens ESI 50
Whole unconditioned medium (Defined culture media, M199),Whole M1 medium,Whole M2 medium (ST000242) Mayo Clinic Homo sapiens ESI 76
Plasma metabolomics: Comparison of non-diabetic controls with T1D patients (ST000045) Mayo Clinic Homo sapiens ESI 48
Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through ?-glucuronidase activity (Part 1) (ST002094) Mayo Clinic Homo sapiens ESI 693

Number of records: 1427

previous 50 records     next 50 records